Literature DB >> 21315702

Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.

Kai-Ping Chang1, Ya-Ting Chang, Chun-Ta Liao, Tzu-Chen Yen, I-How Chen, Yu-Liang Chang, Yu-Ling Liu, Yu-Sun Chang, Jau-Song Yu, Chih-Ching Wu.   

Abstract

BACKGROUND: Oral cavity squamous cell carcinoma (OSCC) is one of the most common cancers worldwide and has been considered to be highly associated with altered biological processes, including immunocyte chemotaxis, inflammatory response, angiogenesis, and/or immune regulation, suggesting that the levels of the tumor-related cytokines and chemokines will be dysregulated in the tumor microenvironment as well as in the systemic circulation and might be associated with some OSCC phenotypes.
METHODS: To profile cytokines in OSCC patients, the plasma levels of 48 proteins (26 cytokines, 10 chemokines, and 12 growth factors) were measured in 111 untreated OSCC patients, 112 healthy individuals, and 107 individuals with oral premalignant lesion (OPL). RESULT: Compared to the plasma levels in the healthy individuals and OPL group, the levels of 12 proteins were significantly dysregulated in the OSCC patients. Further analysis demonstrated that the levels of IFN-α2, IL-2RA, and SCF were significantly lower in patients with higher pT status. IFN-α2 levels also decreased in patients with higher tumor depths. Moreover, OSCC patients with greater levels of VEGF (>4.87 pg/ml) before treatment had worse prognoses for overall survival after treatment (P=0.035).
CONCLUSIONS: This is the first report showing that the plasma VEGF levels may be a useful prognostic indicator of OSCC. Crown
Copyright © 2011. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315702     DOI: 10.1016/j.cca.2011.02.002

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.

Authors:  Yung-Chin Hsiao; Lang-Ming Chi; Kun-Yi Chien; Wei-Fan Chiang; Szu-Fan Chen; Yao-Ning Chuang; Shih-Yu Lin; Chia-Chun Wu; Ya-Ting Chang; Lichieh Julie Chu; Yi-Ting Chen; Shu-Li Chia; Chih-Yen Chien; Kai-Ping Chang; Yu-Sun Chang; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2017-08-18       Impact factor: 5.911

Review 2.  Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.

Authors:  Dante De Paz; Huang-Kai Kao; Yenlin Huang; Kai-Ping Chang
Journal:  Curr Oncol Rep       Date:  2017-08-10       Impact factor: 5.075

3.  Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.

Authors:  Hao-Wei Chu; Kai-Ping Chang; Chia-Wei Hsu; Ian Yi-Feng Chang; Hao-Ping Liu; Yi-Ting Chen; Chih-Ching Wu
Journal:  Mol Cell Proteomics       Date:  2019-06-28       Impact factor: 5.911

4.  Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.

Authors:  Leticia Bagan; Guillermo T Sáez; M Carmen Tormos; Carlos Labaig-Rueda; Judith Murillo-Cortes; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

5.  Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.

Authors:  Kai-Ping Chang; Shih-Jie Lin; Shiau-Chin Liu; Jui-Shan Yi; Kun-Yi Chien; Lang-Ming Chi; Huang-Kai Kao; Ying Liang; Yu-Tsun Lin; Yu-Sun Chang; Jau-Song Yu
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

6.  Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.

Authors:  Li-Hsing Chi; Wei-Min Chang; Yu-Chan Chang; Yung-Chieh Chan; Chia-Chen Tai; Kam-Wing Leung; Chi-Long Chen; Alexander Th Wu; Tsung-Ching Lai; Yu-Chuan Jack Li; Michael Hsiao
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

7.  ASC modulates HIF-1α stability and induces cell mobility in OSCC.

Authors:  Chi-Sheng Wu; Ian Yi-Feng Chang; Jui-Lung Hung; Wei-Chao Liao; Yi-Ru Lai; Kai-Ping Chang; Hsin-Pai Li; Yu-Sun Chang
Journal:  Cell Death Dis       Date:  2020-09-03       Impact factor: 8.469

8.  Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma.

Authors:  Li-Jen Hsin; Huang-Kai Kao; I-How Chen; Ngan-Ming Tsang; Cheng-Lung Hsu; Shiau-Chin Liu; Yu-Sun Chang; Kai-Ping Chang
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

Review 9.  Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer.

Authors:  Gareema Prasad; Michael McCullough
Journal:  Int J Dent       Date:  2013-11-26

Review 10.  The role of serum biomarkers in the diagnosis and prognosis of oral cancer: A systematic review.

Authors:  Ana Fernández-Olavarría; Regina Mosquera-Pérez; Rosa-María Díaz-Sánchez; Maria-Angeles Serrera-Figallo; José-Luis Gutiérrez-Pérez; Daniel Torres-Lagares
Journal:  J Clin Exp Dent       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.